subscribeSubscribe
FDA Rejects Viatris, Mapi’s Long-Acting Multiple Sclerosis Injection

FDA Rejects Viatris, Mapi’s Long-Acting Multiple Sclerosis Injection
BIOSPACE
12 Mar 2024
Share Share
Teva delays high-stakes kickbacks trial with rare early appeal

Teva delays high-stakes kickbacks trial with rare early appeal
Zoey Becker FIERCE PHARMA
17 Aug 2023
Share Share
Obesity drugs don`t make WHO`s essential list, but Ebola, MS drugs added

Obesity drugs don`t make WHO`s essential list, but Ebola, MS drugs added
REUTERS
27 Jul 2023
Share Share
Stem cell transplants may slow disability progression in MS

Stem cell transplants may slow disability progression in MS
Caroline Peachey EUROPEANPHARMACEUTICALREVIEW
22 Dec 2022
Share Share
FDA alerts patients, and health care providers of cross-compatibility issues

FDA alerts patients, and health care providers of cross-compatibility issues
RAPS
18 Aug 2022
Share Share
Teva faces $100M claim by Israel over Copaxone royalties: report

Teva faces $100M claim by Israel over Copaxone royalties: report
Eric Sagonowsky FIERCEPHARMA
11 May 2022
Share Share
COPAXONE Label Now Indicates Its Use in Breastfeeding Mothers with RMS

COPAXONE Label Now Indicates Its Use in Breastfeeding Mothers with RMS
BUSINESSWIRE
10 Feb 2022
Share Share
Multiple sclerosis drug improves memory in mice modeling Alzheimer’s disease

Multiple sclerosis drug improves memory in mice modeling Alzheimer’s disease
FIRSTWORDPHARMA
07 Nov 2021
Share Share
Teva`s Austedo struggling from pandemic slowdown; All eyes on Q4

Teva`s Austedo struggling from pandemic slowdown; All eyes on Q4
Eric Sagonowsky FIERCEPHARMA
27 Oct 2021
Share Share
New Safety Data on treatment with COPAXONE of Breastfeeding Mothers with MS

New Safety Data on treatment with COPAXONE of Breastfeeding Mothers with MS
BUSINESSWIRE
13 Oct 2021
Share Share